First, the high levels of C14orf119 and C5orf46 gene expression (gene signature I) correlate with poor OS in PAAD (16.6 vs. 30.4 months, HR = 2.1 (1.37–3.18), p-value < 0.001). This evidence concerns the gene C5orf46 and pancreatic adenocarcinoma.